[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
May 1955

Systemic Mast-Cell Disease with: Urticaria Pigmentosa

Author Affiliations

Long Beach, Calif.

From the Laboratory, Dermatology and Investigative Medicine Services, Veterans Administration Hospital.

AMA Arch Derm. 1955;71(5):561-569. doi:10.1001/archderm.1955.01540290001001
Abstract

The proliferation of mast cells in the skin of patients with urticaria pigmentosa has been well described.* We would present the findings in systemic mast-cell disease suggesting that the disseminate variety of disease may be more frequent than has been previously recognized. Further, some ideas regarding the mast cell and its function are listed to explain certain of the findings here noted. The possible action of the mast cell in the inflammatory response is also considered.

I. SYSTEMIC MAST-CELL DISEASE

Urticaria pigmentosa ordinarily occurs in childhood, with approximately 70% of the total recorded cases1 having their onset in the first year. The characteristic cutaneous lesions are macules, papules, or, less frequently, nodules which vary from yellow-brown to violet. The tendency of these lesions when irritated to urticate is the basis for the name of the disease. The trunk is ordinarily the most extensively

References
1.
References 1 and 2.
2.
References 3 to 5 and Sagher, F.: Personal communication to the authors.
3.
References 6 to 8.
4.
References 10 to 12.
5.
References 13 and 14.
6.
References 15 to 19.
7.
References 22 and 23.
8.
References 24 and 25.
9.
References 26 and 28.
10.
Ormsby, O. S., and Montgomery, H.:  Diseases of the Skin , Ed. 7, Philadelphia, Lea & Febiger, 1948, pp. 177-181.
11.
Lever, W. F.:  Histopathology of the Skin , Philadelphia, J. B. Lippincott Company, 1949, p. 49.
12.
Sagher, F.; Cohen, C., and Schorr, S.:  Concomitant Bone Changes in Urticaria Pigmentosa ,  J. Invest. Dermat. 18:425-432, 1952.
13.
Clyman, S. G., and Rein, C. R.:  Urticaria Pigmentosa Associated with Bone Lesions: A Summary and Report of 8 Cases ,  J. Invest. Dermat. 19:179-185, 1952.Crossref
14.
Calnan, C. D.:  Urticaria Pigmentosa with Bone Lesions: 2 Cases ,  Proc. Roy. Soc. Med. 46: 544-555, 1953.
15.
Hissard, R.; Moncourier, F., and Jacquet, J.:  Une nouvelle affection hématodermique, la mastocytose ,  Compt. rend. Acad. sc. 231:253-255, 1950.
16.
Ellis, J. M.:  Urticaria Pigmentosa ,  Arch. Path. 48:426-435, 1949.
17.
Touraine, Solente, and Renault, P.:  Urticaire pigmentaire avec réaction splénique et myélémique ,  Bull. Soc. franç. dermat. et syph. 40:1691-1694, 1933.
18.
Bloom, F.:  Spontaneous Solitary and Multiple Mast Cell Tumors ,  Arch. Path. 33:661-676, 1942.
19.
Paff, G. H.; Bloom, F., and Reilly, C.:  The Morphology and Behavior of Neoplastic Mast Cells Cultivated in Vitro ,  J. Exper. Med. 86:117-123, 1947.Crossref
20.
Zitcer, E. M., and Kirk, P. L.:  The Effect of Serum Ultrafiltrate on Cultivated Mast Cells and Fibroblasts from Human Skin ,  Science 119:99, 1954.Crossref
21.
Zitcer, E. M.; Elisasser, W. H., and Kirk, P. L.:  Cultivation and Morphology of Human Tissue Mast Cells in Vitro ,  Growth 17:111-122, 1953.
22.
Fadem, R.:  Tissue Mast Cells in Human Bone Marrow ,  Blood 6:614-630, 1951.
23.
Williams, F. T.:  Tissue Mast Cells in Human Bone Marrow ,  Am. J. Clin. Path. 22:1039-1043, 1952.
24.
Jorpes, J. E.:  Heparin in the Treatment of Thrombosis , Ed. 2, New York and London, Oxford University Press, 1946, p. 66.
25.
Riley, J. F., and West, G. B.:  The Presence of Histamine in Tissue Mast Cells ,  J. Physiol. 120: 528-37, 1953.
26.
Riley, J. F., and West, G. B.:  Mast Cells and Histamine in Normal and Pathological Tissues ,  J. Physiol. 119:44-45, 1953.
27.
Asboe-Hansen, G.:  Om bindevaivets mucinose substanser , Copenhagen, Rosenkilde and Bagger, 1951.
28.
Riley, J. F., and West, G. B.:  Heparin in Tissue Mast Cells ,  J. Physiol. 117:72-73, 1952.
29.
Oliver, J.; Bloom, F., and Mangieri, E.:  On the Origin of Heparin: Examination of the Heparin Content and the Specific Cytoplasmic Particles of Neoplastic Mast Cells ,  J. Exper. Med. 86:107-116, 1947.Crossref
30.
Graham, D.; Lyon, T.; Gofman, J.; Jones, H.; Tonkley, A.; Simonton, J., and White, S.:  Blood Lipids and Human Atherosclerosis: II. Influence of Heparin on Lipoprotein Metabolism ,  Circulation 4:666-673, 1951.Crossref
31.
Cairns, A., and Constantinides, P.:  Mast Cells in Human Atherosclerosis ,  Science 120:31-32, 1954.Crossref
32.
Constantinides, P.:  Mast Cells and Susceptibility to Experimental Atherosclerosis ,  Science 117:505-506, 1953.Crossref
33.
Pierce, F.:  Relationship of ACTH and Cortisone to the Serum Lipoproteins of the Rabbit ,  Metabolism 1:163-171, 1952.
34.
Bloom, B., and Pierce, F. T.:  Relationship of ACTH and Cortisone to Serum Lipoproteins and Atherosclerosis in Humans ,  Metabolism 1:155-162, 1952.
35.
Asboe-Hansen, G.:  The Mast Cell and Object of Cortisone Action on Connective Tissue ,  Proc. Soc. Exper. Biol. & Med. 80:677-679, 1952.
36.
Riley, J. F., and West, G. B.:  The Presence of Histamine in Tissue Mast Cells ,  J. Physiol. 120: 528-537, 1952.
37.
Cavallero, C., and Braccini, C.:  Effect of Cortisone on the Mast Cells of the Rat ,  Proc. Soc. Exper. Biol. & Med. 78:141-143, 1951.
38.
Devitt, J. E.; Samuels, P. B.; Pirozynski, W. J., and Webster, D. R.:  Morphology of Tissue Mast Cells: The Frequency of Artefacts and the Influence of Certain Biologic Agents ,  Am. J. Path. 30:391-398, 1954.
39.
Morrione, T. G.:  Formation of Collagen Fibers by the Action of Heparin on Soluble Collagen ,  J. Exper. Med. 96:107-114, 1952.
40.
Highberger, J.; Gross, J., and Schmitt, F.:  The Interaction of Mucoprotein with Soluble Collagen: An Electron Microscope Study ,  Proc. Nat. Acad. Sc. 37:286-291, 1951.
41.
Menkin, V.:  Newer Concepts of Inflammation , Pub. No. 70,  American Lectures in Dentistry , Springfield, Ill., Charles C Thomas, Publisher, 1950, pp. 23-29.
×